Skip to main content

View full-text article in PMC

. 2021 Jul 17;96(5):551–557. doi: 10.1016/j.abd.2021.03.006

Table 5.

Interleukin levels and Severity of Alopecia Tool scores in the patients receiving tofacitinib treatment.

	Pre-treatment (n = 22)	Post-treatment (n = 22)	p
	Median (Q1–Q3)	Median (Q1–Q3)	p
SALT score	100 (50–100)	40 (24–50)	< 0.001
IL level
IL-2	346.92 (314.08–462.66)	248.96 (174.55–298.89)	< 0.001
IL-4	317.16 (276.71–504.72)	152.0 (128.08–290.31)	0.022
IL-15	208.86 (125.64–490.64)	122.82 (68.36–200.4)	0.033
IL-17	88.69 (64.88–107.74)	49.32 (38.77–82.34)	0.016

IL, Interleukin; SALT, Severity of Alopecia Tool.